US 11714089
Combination of markers for diagnosing cancer
granted A61KA61K45/06A61P
Quick answer
US patent 11714089 (Combination of markers for diagnosing cancer) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
- Grant date
- Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00